Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE159099 | GEO | 2025/03/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [WES]

Project description:Whole exome sequencing in order to characterise genomic alterations from patients with Ampullary carcinoma (AMPAC)

2025-03-25 | GSE159098 | GEO

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [RNA]

Project description:Expression profiling by high throughput sequencing in order to analyze the differential profile of RNAs expression from patients with Ampullary carcinoma (AMPAC)

2025-03-25 | GSE159097 | GEO

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [methylation]

Project description:RNA-seq, methylation and Whole exome sequencing in order to characterise genomic alterations from patients with Ampullary carcinoma (AMPAC)

2025-03-25 | GSE159096 | GEO

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma

| PRJNA667701 | ENA

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [methylation]

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [methylation]

| PRJNA667702 | ENA

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [RNA]

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [RNA]

| PRJNA667801 | ENA

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [WES]

Project description:Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [WES]

| PRJNA667802 | ENA

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Project description:Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. In this study, we conducted whole genome gene expression analysis of 96 human scalp skin biopsy specimens from AA or normal control subjects. Based on gene expression profiling, samples formed distinct clusters based on the presence or absence of disease as well as disease phenotype (patchy disease compared with alopecia totalis or universalis). Differential gene expression analysis allowed us to robustly demonstrate graded immune activity in samples of increasing phenotypic severity and generate a quantitative gene expression scoring system that classified samples based on interferon and cytotoxic T lymphocyte immune signatures critical for disease pathogenesis.

| S-EPMC4909368 | biostudies-literature

Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-05-17 | E-GEOD-74312 | biostudies-arrayexpress

Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma.

Project description:Treatment effectiveness in hepatocellular carcinoma (HCC) depends on early detection and precision-medicine-based patient stratification for targeted therapies. However, the lack of robust biomarkers, particularly a non-invasive diagnostic tool, precludes significant improvement of clinical outcomes for HCC patients. Serum metabolites are one of the best non-invasive means for determining patient prognosis, as they are stable end-products of biochemical processes in human body. In this study, we aimed to identify prognostic serum metabolites in HCC. To determine serum metabolites that were relevant and representative of the tissue status, we performed a two-step correlation analysis to first determine associations between metabolic genes and tissue metabolites, and second, between tissue metabolites and serum metabolites among 49 HCC patients, which were then validated in 408 additional Asian HCC patients with mixed etiologies. We found that certain metabolic genes, tissue metabolites and serum metabolites can independently stratify HCC patients into prognostic subgroups, which are consistent across these different data types and our previous findings. The metabolic subtypes are associated with β-oxidation process in fatty acid metabolism, where patients with worse survival outcome have dysregulated fatty acid metabolism. These serum metabolites may be used as non-invasive biomarkers to define prognostic tumor molecular subtypes for HCC.

| S-EPMC8187378 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data